(As of May. 1,2019)


Japanese

(3)Advanced Medical and Dental Treatment

Items Date Initiated
Concurrent therapy with intravenous pemetrexed and cisplatin administration Lung Cancer
(Only cases judged to have been completely excised pathologically excluding squamous lung cancer and small cell lung cancer)
Sep. 1,2012
Percutaneous radiofrequency ablation (RFA) (Breast cancer) Aug. 1,2013
A multicenter randomized phase Ⅲ study for recurrent glioblastoma comparing bevacizumab alone with dose-dense temozolomide followed by bevacizumab (JCOG1308C, RE-GEND-pⅢ) Jan. 1,2018
Phase Ⅲ Study of High-dose Methotrexate and Whole Brain Rdiotherapy With or Without Concomitant and Adjuvant Temozolomide in Patients with Primary CNS Lymphoma (JCOG1114C, PCNSL-TMZ-P3) Jan. 1,2018
Multiplex genetic panel test Advanced or recurrent cancers (For the cases of unresectable carcinoma due to far advancement or for the cases of post-operative recurrence with unknown origin or with no standard therapeutic regimens; limited to the cases who have actually or almost ended with conventional therapies) Aug. 1,2018